Cargando…

Natural History of Progression of HPV Infection to Cervical Lesion or Clearance: Analysis of the Control Arm of the Large, Randomised PATRICIA Study

BACKGROUND: The control arm of PATRICIA (PApillomaTRIal against Cancer In young Adults, NCT00122681) was used to investigate the risk of progression from cervical HPV infection to cervical intraepithelial neoplasia (CIN) or clearance of infection, and associated determinants. METHODS AND FINDINGS: W...

Descripción completa

Detalles Bibliográficos
Autores principales: Jaisamrarn, Unnop, Castellsagué, Xavier, Garland, Suzanne M., Naud, Paulo, Palmroth, Johanna, Del Rosario-Raymundo, Maria Rowena, Wheeler, Cosette M., Salmerón, Jorge, Chow, Song-Nan, Apter, Dan, Teixeira, Julio C., Skinner, S. Rachel, Hedrick, James, Szarewski, Anne, Romanowski, Barbara, Aoki, Fred Y., Schwarz, Tino F., Poppe, Willy A. J., Bosch, F. Xavier, de Carvalho, Newton S., Germar, Maria Julieta, Peters, Klaus, Paavonen, Jorma, Bozonnat, Marie-Cecile, Descamps, Dominique, Struyf, Frank, Dubin, Gary O., Rosillon, Dominique, Baril, Laurence
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3834039/
https://www.ncbi.nlm.nih.gov/pubmed/24260180
http://dx.doi.org/10.1371/journal.pone.0079260
_version_ 1782291929021546496
author Jaisamrarn, Unnop
Castellsagué, Xavier
Garland, Suzanne M.
Naud, Paulo
Palmroth, Johanna
Del Rosario-Raymundo, Maria Rowena
Wheeler, Cosette M.
Salmerón, Jorge
Chow, Song-Nan
Apter, Dan
Teixeira, Julio C.
Skinner, S. Rachel
Hedrick, James
Szarewski, Anne
Romanowski, Barbara
Aoki, Fred Y.
Schwarz, Tino F.
Poppe, Willy A. J.
Bosch, F. Xavier
de Carvalho, Newton S.
Germar, Maria Julieta
Peters, Klaus
Paavonen, Jorma
Bozonnat, Marie-Cecile
Descamps, Dominique
Struyf, Frank
Dubin, Gary O.
Rosillon, Dominique
Baril, Laurence
author_facet Jaisamrarn, Unnop
Castellsagué, Xavier
Garland, Suzanne M.
Naud, Paulo
Palmroth, Johanna
Del Rosario-Raymundo, Maria Rowena
Wheeler, Cosette M.
Salmerón, Jorge
Chow, Song-Nan
Apter, Dan
Teixeira, Julio C.
Skinner, S. Rachel
Hedrick, James
Szarewski, Anne
Romanowski, Barbara
Aoki, Fred Y.
Schwarz, Tino F.
Poppe, Willy A. J.
Bosch, F. Xavier
de Carvalho, Newton S.
Germar, Maria Julieta
Peters, Klaus
Paavonen, Jorma
Bozonnat, Marie-Cecile
Descamps, Dominique
Struyf, Frank
Dubin, Gary O.
Rosillon, Dominique
Baril, Laurence
author_sort Jaisamrarn, Unnop
collection PubMed
description BACKGROUND: The control arm of PATRICIA (PApillomaTRIal against Cancer In young Adults, NCT00122681) was used to investigate the risk of progression from cervical HPV infection to cervical intraepithelial neoplasia (CIN) or clearance of infection, and associated determinants. METHODS AND FINDINGS: Women aged 15-25 years were enrolled. A 6-month persistent HPV infection (6MPI) was defined as detection of the same HPV type at two consecutive evaluations over 6 months and clearance as ≥2 type-specific HPV negative samples taken at two consecutive intervals of approximately 6 months following a positive sample. The primary endpoint was CIN grade 2 or greater (CIN2+) associated with the same HPV type as a 6MPI. Secondary endpoints were CIN1+/CIN3+ associated with the same HPV type as a 6MPI; CIN1+/CIN2+/CIN3+ associated with an infection of any duration; and clearance of infection. The analyses included 4825 women with 16,785 infections (3363 womenwith 6902 6MPIs). Risk of developing a CIN1+/CIN2+/CIN3+ associated with same HPV type as a 6MPI varied with HPV type and was significantly higher for oncogenic versus non-oncogenic types. Hazard ratios for development of CIN2+ were 10.44 (95% CI: 6.96-15.65), 9.65 (5.97-15.60), 5.68 (3.50-9.21), 5.38 (2.87-10.06) and 3.87 (2.38-6.30) for HPV-16, HPV-33, HPV-31, HPV-45 and HPV-18, respectively. HPV-16 or HPV-33 6MPIs had ~25-fold higher risk for progression to CIN3+. Previous or concomitant HPV infection or CIN1+ associated with a different HPV type increased risk. Of the different oncogenic HPV types, HPV-16 and HPV-31 infections were least likely to clear. CONCLUSIONS: Cervical infections with oncogenic HPV types increased the risk of CIN2+ and CIN3+. Previous or concomitant infection or CIN1+ also increased the risk. HPV-16 and HPV-33 have by far the highest risk of progression to CIN3+, and HPV-16 and HPV-31 have the lowest chance of clearance.
format Online
Article
Text
id pubmed-3834039
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-38340392013-11-20 Natural History of Progression of HPV Infection to Cervical Lesion or Clearance: Analysis of the Control Arm of the Large, Randomised PATRICIA Study Jaisamrarn, Unnop Castellsagué, Xavier Garland, Suzanne M. Naud, Paulo Palmroth, Johanna Del Rosario-Raymundo, Maria Rowena Wheeler, Cosette M. Salmerón, Jorge Chow, Song-Nan Apter, Dan Teixeira, Julio C. Skinner, S. Rachel Hedrick, James Szarewski, Anne Romanowski, Barbara Aoki, Fred Y. Schwarz, Tino F. Poppe, Willy A. J. Bosch, F. Xavier de Carvalho, Newton S. Germar, Maria Julieta Peters, Klaus Paavonen, Jorma Bozonnat, Marie-Cecile Descamps, Dominique Struyf, Frank Dubin, Gary O. Rosillon, Dominique Baril, Laurence PLoS One Research Article BACKGROUND: The control arm of PATRICIA (PApillomaTRIal against Cancer In young Adults, NCT00122681) was used to investigate the risk of progression from cervical HPV infection to cervical intraepithelial neoplasia (CIN) or clearance of infection, and associated determinants. METHODS AND FINDINGS: Women aged 15-25 years were enrolled. A 6-month persistent HPV infection (6MPI) was defined as detection of the same HPV type at two consecutive evaluations over 6 months and clearance as ≥2 type-specific HPV negative samples taken at two consecutive intervals of approximately 6 months following a positive sample. The primary endpoint was CIN grade 2 or greater (CIN2+) associated with the same HPV type as a 6MPI. Secondary endpoints were CIN1+/CIN3+ associated with the same HPV type as a 6MPI; CIN1+/CIN2+/CIN3+ associated with an infection of any duration; and clearance of infection. The analyses included 4825 women with 16,785 infections (3363 womenwith 6902 6MPIs). Risk of developing a CIN1+/CIN2+/CIN3+ associated with same HPV type as a 6MPI varied with HPV type and was significantly higher for oncogenic versus non-oncogenic types. Hazard ratios for development of CIN2+ were 10.44 (95% CI: 6.96-15.65), 9.65 (5.97-15.60), 5.68 (3.50-9.21), 5.38 (2.87-10.06) and 3.87 (2.38-6.30) for HPV-16, HPV-33, HPV-31, HPV-45 and HPV-18, respectively. HPV-16 or HPV-33 6MPIs had ~25-fold higher risk for progression to CIN3+. Previous or concomitant HPV infection or CIN1+ associated with a different HPV type increased risk. Of the different oncogenic HPV types, HPV-16 and HPV-31 infections were least likely to clear. CONCLUSIONS: Cervical infections with oncogenic HPV types increased the risk of CIN2+ and CIN3+. Previous or concomitant infection or CIN1+ also increased the risk. HPV-16 and HPV-33 have by far the highest risk of progression to CIN3+, and HPV-16 and HPV-31 have the lowest chance of clearance. Public Library of Science 2013-11-19 /pmc/articles/PMC3834039/ /pubmed/24260180 http://dx.doi.org/10.1371/journal.pone.0079260 Text en © 2013 Jaisamrarn et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
spellingShingle Research Article
Jaisamrarn, Unnop
Castellsagué, Xavier
Garland, Suzanne M.
Naud, Paulo
Palmroth, Johanna
Del Rosario-Raymundo, Maria Rowena
Wheeler, Cosette M.
Salmerón, Jorge
Chow, Song-Nan
Apter, Dan
Teixeira, Julio C.
Skinner, S. Rachel
Hedrick, James
Szarewski, Anne
Romanowski, Barbara
Aoki, Fred Y.
Schwarz, Tino F.
Poppe, Willy A. J.
Bosch, F. Xavier
de Carvalho, Newton S.
Germar, Maria Julieta
Peters, Klaus
Paavonen, Jorma
Bozonnat, Marie-Cecile
Descamps, Dominique
Struyf, Frank
Dubin, Gary O.
Rosillon, Dominique
Baril, Laurence
Natural History of Progression of HPV Infection to Cervical Lesion or Clearance: Analysis of the Control Arm of the Large, Randomised PATRICIA Study
title Natural History of Progression of HPV Infection to Cervical Lesion or Clearance: Analysis of the Control Arm of the Large, Randomised PATRICIA Study
title_full Natural History of Progression of HPV Infection to Cervical Lesion or Clearance: Analysis of the Control Arm of the Large, Randomised PATRICIA Study
title_fullStr Natural History of Progression of HPV Infection to Cervical Lesion or Clearance: Analysis of the Control Arm of the Large, Randomised PATRICIA Study
title_full_unstemmed Natural History of Progression of HPV Infection to Cervical Lesion or Clearance: Analysis of the Control Arm of the Large, Randomised PATRICIA Study
title_short Natural History of Progression of HPV Infection to Cervical Lesion or Clearance: Analysis of the Control Arm of the Large, Randomised PATRICIA Study
title_sort natural history of progression of hpv infection to cervical lesion or clearance: analysis of the control arm of the large, randomised patricia study
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3834039/
https://www.ncbi.nlm.nih.gov/pubmed/24260180
http://dx.doi.org/10.1371/journal.pone.0079260
work_keys_str_mv AT jaisamrarnunnop naturalhistoryofprogressionofhpvinfectiontocervicallesionorclearanceanalysisofthecontrolarmofthelargerandomisedpatriciastudy
AT castellsaguexavier naturalhistoryofprogressionofhpvinfectiontocervicallesionorclearanceanalysisofthecontrolarmofthelargerandomisedpatriciastudy
AT garlandsuzannem naturalhistoryofprogressionofhpvinfectiontocervicallesionorclearanceanalysisofthecontrolarmofthelargerandomisedpatriciastudy
AT naudpaulo naturalhistoryofprogressionofhpvinfectiontocervicallesionorclearanceanalysisofthecontrolarmofthelargerandomisedpatriciastudy
AT palmrothjohanna naturalhistoryofprogressionofhpvinfectiontocervicallesionorclearanceanalysisofthecontrolarmofthelargerandomisedpatriciastudy
AT delrosarioraymundomariarowena naturalhistoryofprogressionofhpvinfectiontocervicallesionorclearanceanalysisofthecontrolarmofthelargerandomisedpatriciastudy
AT wheelercosettem naturalhistoryofprogressionofhpvinfectiontocervicallesionorclearanceanalysisofthecontrolarmofthelargerandomisedpatriciastudy
AT salmeronjorge naturalhistoryofprogressionofhpvinfectiontocervicallesionorclearanceanalysisofthecontrolarmofthelargerandomisedpatriciastudy
AT chowsongnan naturalhistoryofprogressionofhpvinfectiontocervicallesionorclearanceanalysisofthecontrolarmofthelargerandomisedpatriciastudy
AT apterdan naturalhistoryofprogressionofhpvinfectiontocervicallesionorclearanceanalysisofthecontrolarmofthelargerandomisedpatriciastudy
AT teixeirajulioc naturalhistoryofprogressionofhpvinfectiontocervicallesionorclearanceanalysisofthecontrolarmofthelargerandomisedpatriciastudy
AT skinnersrachel naturalhistoryofprogressionofhpvinfectiontocervicallesionorclearanceanalysisofthecontrolarmofthelargerandomisedpatriciastudy
AT hedrickjames naturalhistoryofprogressionofhpvinfectiontocervicallesionorclearanceanalysisofthecontrolarmofthelargerandomisedpatriciastudy
AT szarewskianne naturalhistoryofprogressionofhpvinfectiontocervicallesionorclearanceanalysisofthecontrolarmofthelargerandomisedpatriciastudy
AT romanowskibarbara naturalhistoryofprogressionofhpvinfectiontocervicallesionorclearanceanalysisofthecontrolarmofthelargerandomisedpatriciastudy
AT aokifredy naturalhistoryofprogressionofhpvinfectiontocervicallesionorclearanceanalysisofthecontrolarmofthelargerandomisedpatriciastudy
AT schwarztinof naturalhistoryofprogressionofhpvinfectiontocervicallesionorclearanceanalysisofthecontrolarmofthelargerandomisedpatriciastudy
AT poppewillyaj naturalhistoryofprogressionofhpvinfectiontocervicallesionorclearanceanalysisofthecontrolarmofthelargerandomisedpatriciastudy
AT boschfxavier naturalhistoryofprogressionofhpvinfectiontocervicallesionorclearanceanalysisofthecontrolarmofthelargerandomisedpatriciastudy
AT decarvalhonewtons naturalhistoryofprogressionofhpvinfectiontocervicallesionorclearanceanalysisofthecontrolarmofthelargerandomisedpatriciastudy
AT germarmariajulieta naturalhistoryofprogressionofhpvinfectiontocervicallesionorclearanceanalysisofthecontrolarmofthelargerandomisedpatriciastudy
AT petersklaus naturalhistoryofprogressionofhpvinfectiontocervicallesionorclearanceanalysisofthecontrolarmofthelargerandomisedpatriciastudy
AT paavonenjorma naturalhistoryofprogressionofhpvinfectiontocervicallesionorclearanceanalysisofthecontrolarmofthelargerandomisedpatriciastudy
AT bozonnatmariececile naturalhistoryofprogressionofhpvinfectiontocervicallesionorclearanceanalysisofthecontrolarmofthelargerandomisedpatriciastudy
AT descampsdominique naturalhistoryofprogressionofhpvinfectiontocervicallesionorclearanceanalysisofthecontrolarmofthelargerandomisedpatriciastudy
AT struyffrank naturalhistoryofprogressionofhpvinfectiontocervicallesionorclearanceanalysisofthecontrolarmofthelargerandomisedpatriciastudy
AT dubingaryo naturalhistoryofprogressionofhpvinfectiontocervicallesionorclearanceanalysisofthecontrolarmofthelargerandomisedpatriciastudy
AT rosillondominique naturalhistoryofprogressionofhpvinfectiontocervicallesionorclearanceanalysisofthecontrolarmofthelargerandomisedpatriciastudy
AT barillaurence naturalhistoryofprogressionofhpvinfectiontocervicallesionorclearanceanalysisofthecontrolarmofthelargerandomisedpatriciastudy
AT naturalhistoryofprogressionofhpvinfectiontocervicallesionorclearanceanalysisofthecontrolarmofthelargerandomisedpatriciastudy